Composition : Capsule 15 : Lansoprazole 15 mg.
Capsule 30 : Lansoprazole 30 mg.
Indications : benign gastric ulcer, duodenal ulcer, NSAID-associated duodenal or gastric ulcer, peptic ulcer associated with H. pylori, Zollinger-Ellison syndrome, gastro-esophageal reflux disease and acid-related dyspepsia.
Dosage & Administration : Benign gastric ulcer : 30 mg daily for 8 weeks. Duodenal ulcer : 30 mg daily for 4 weeks. NSAID-associated duodenal or gastric ulcer : 15-30 mg once daily for 4 weeks. Further 4 weeks can be given if not fully healed.
Peptic ulcer associated with H. Pylori (Triple therapy)
|
Regimens
|
Dosage
|
Duration
|
|
Lansoprazole (Lansodin ®)
Clarithromycin (Claricin)
Amoxicillin (Moxilin)
|
30 mg twice daily
500 mg twice daily
1 g twice daily
|
01 week
|
|
Lansoprazole (Lansodin ®)
Clarithromycin (Claricin)
Metronidazole (Dirozyl)
|
30 mg twice daily
500 mg twice daily
400 mg twice daily
|
01 week
|
|
Lansoprazole (Lansodin ®)
Amoxicillin (Moxilin)
Metronidazole (Dirozyl)
|
30 mg twice daily
1 g twice daily
400 mg twice daily
|
01 week
|
Zollinger-Ellison syndrome : Initially 60 mg once daily adjusted according to response. Daily doses of 120 mg or more given in two divided doses.
Gastro-esophageal reflux disease : 30 mg daily in the morning for 4 weeks. Further 4 weeks can be given if not fully healed. Maintenance dose : 15 – 30 mg daily.
Acid-related dyspepsia : 15 – 30 mg daily in the morning for 2 – 4 weeks.
